Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Short-Term Debt issuances (2023 - 2025)

iBio (IBIO) has disclosed Short-Term Debt issuances for 2 consecutive years, with $105000.0 as the latest value for Q3 2025.

  • Quarterly Short-Term Debt issuances changed N/A to $105000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $105000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at $204000.0 for FY2024, N/A changed from the prior year.
  • Short-Term Debt issuances for Q3 2025 was $105000.0 at iBio, down from $204000.0 in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $204000.0 in Q3 2023, with the low at $105000.0 in Q3 2025.